# doxorubicin hydrochloride

NDC: 68001-706
Generic name: doxorubicin hydrochloride
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SUSPENSION, LIPOSOMAL
Routes: INTRAVENOUS
Marketing started: 20260710

FDA application: ANDA219199

## Active ingredients

- DOXORUBICIN HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-706"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-706
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55889588-c5f1-d9bc-e063-6294a90a5791